evaluation of topical niosomal zinc sulphate in leishmaniasis
Phase 2
Recruiting
- Conditions
- Acute cutaneous leishmaniaisis.Cutaneous leishmaniasis
- Registration Number
- IRCT20170806035524N4
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
acute cutaneous leishmaniasis(urban type)
duration less than 6 months
wash out period of 1 month
Exclusion Criteria
pregnancy
nursing
age less than 2 years old
number of lesions more than 5
sensitization to zinc sulphate or glucantime
lesions on face or joint
lesions larger than 5 centimeter
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in induration of the lesion. Timepoint: at BASE -LINE AND IN 2,4,6,8,10,12 WEEKS and 3 months after end of the treatment. Method of measurement: by measuring induration of the lesions (largest diameter) by transparent paper.
- Secondary Outcome Measures
Name Time Method